drugset / Trial / NCT03612440

Effects of Dexmedetomidine on OI, RI and Inflammatory Factors in Patients Undergoing Palatopalatyngoplasty.

NCT03612440 ↗

RandomizedParallel-groupTriple-blindOther

Summary

The purpose of this study is to investigate the efficacy of dexmedetomidine on oxygenation index, respiratory index and inflammatory factors, and to explore the protective effect of the dexmedetomidine on respiratory function in patients undergoing palatopalatyngoplasty.

Timeline

Start
2018-08-01
Primary completion
2019-04-30
Completion
2019-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.4 ug/kg —

Indications

No indication recorded.